Gefitinib, an EGFR Tyrosine Kinase inhibitor, Prevents Smoke-Mediated Ciliated Airway Epithelial Cell Loss and Promotes Their Recovery

Title
Gefitinib, an EGFR Tyrosine Kinase inhibitor, Prevents Smoke-Mediated Ciliated Airway Epithelial Cell Loss and Promotes Their Recovery
Authors
Keywords
Smoking habits, Cell differentiation, Smoking related disorders, EGFR signaling, Epithelial cells, Cell staining, Lung development, Nuclear staining
Journal
PLoS One
Volume 11, Issue 8, Pages e0160216
Publisher
Public Library of Science (PLoS)
Online
2016-08-18
DOI
10.1371/journal.pone.0160216

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started